EPISODE · May 28, 2025 · 8 MIN
66. GLP-1类药物的广泛益处
from 知为谁 · host 知为谁
此《华尔街日报》文章探讨了 GLP-1 类药物（如 Ozempic）日益增长的潜力，指出它们除了治疗糖尿病和肥胖症的常见用途外，还可能对一系列疾病有效。 文章强调了这些药物在改善心脏、肾脏、肝脏疾病、睡眠呼吸暂停甚至阿尔茨海默病和关节炎等方面的希望，尽管其中一些益处仍需进一步研究。 然而，作者也提到了可能出现的过度减肥风险以及药物昂贵的成本， 这限制了更多患者的使用，尽管符合条件的成年人数量庞大。 文章最后指出，尽管存在生产和耐受性方面的挑战，但未来的研究和新药开发可能会进一步扩大 GLP-1 药物的影响力。内容来源：https://www.wsj.com/health/pharma/glp-1-drugs-health-benefits-4014d7d5
Embed this episode
NOW PLAYING
66. GLP-1类药物的广泛益处
0:00
8:34
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 知为谁?
This episode is 8 minutes long.
When was this 知为谁 episode published?
This episode was published on May 28, 2025.
Can I download this 知为谁 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!